In a bylined article, Litigation & Dispute Resolution partners Mark Mansour and Christopher Mikson and associate Emily Strunk (all Washington DC) discuss guidance the FDA has issued addressing the higher standard for interchangeability.


To read this complete article visit Law360.
Downloads –